Thor Medical ASA (OSL:TRMED) Dividends per Share : kr0.00 (TTM As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Thor Medical ASA Dividends per Share?

Thor Medical ASA's dividends per share for the six months ended in Dec. 2024 was kr0.00. Its dividends per share for the trailing twelve months (TTM) ended in Dec. 2024 was kr0.00. Its Dividend Payout Ratio for the six months ended in Dec. 2024 was 0.00. As of today, Thor Medical ASA's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Thor Medical ASA Dividends per Share Historical Data

The historical data trend for Thor Medical ASA's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Thor Medical ASA Dividends per Share Chart

Thor Medical ASA Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dividends per Share

Get a 7-Day Free Trial

Thor Medical ASA Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Dividends per Share	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Thor Medical ASA's Dividends per Share

For the Biotechnology subindustry, Thor Medical ASA's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Thor Medical ASA's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Thor Medical ASA's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Thor Medical ASA's Dividend Yield % falls into.

Save Embed

;

Save Embed

;

Thor Medical ASA Dividends per Share Calculation

Dividends paid to per common share.

Thor Medical ASA (OSL:TRMED) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Thor Medical ASA's Dividend Payout Ratio for the quarter that ended in Dec. 2024 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Dec. 2024 )	/	EPS without NRI (Q: Dec. 2024 )
	=	0	/	-0.123
	=	N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Thor Medical ASA Dividends per Share Related Terms

Thank you for viewing the detailed overview of Thor Medical ASA's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Thor Medical ASA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Thor Medical ASA (OSL:TRMED) » Definitions » Dividends per Share

Comparable Companies

Traded in Other Exchanges

0R6Y:UK 8NN:Germany

Address

Karenslyst Alle 9C, Oslo, NOR, 0278

Website

https://www.thormedical.no

Thor Medical ASA is a Norway-based biopharmaceutical company. The Company is a producer and supplier of alpha-particle emitters for cancer therapy. The production process is based on separation of natural occurring radioactive decay products from thorium. The Company is utilizing alpha-emitters in radiotherapy and cancer treatments using Pb-212, which can be produced from naturally occurring isotope Thorium-232 and Lead-212. The Company has developed a proprietary technology for the manufacturing of radionuclides, alpha-particle emitters from natural resources. The high energy deposition and the short range of alpha particles make it possible to eradicate cancer cells while minimizing damage to nearby healthy cells.

Thor Medical ASA Headlines

No Headlines